New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Cytosorbents Corporation (CTSO) vs CVRx, Inc. (CVRX)

Cytosorbents Corporation and CVRx, Inc. are both Medical Devices companies. Cytosorbents Corporation and CVRx, Inc. are of similar size ($17.5M and $17.2M). CVRx, Inc. grew revenue faster over the last twelve months: 7.79% against 3.07%. Cytosorbents Corporation has the higher net margin (−48.9% vs −88.3%) and the higher return on invested capital (−66.9% vs −225.0%). Across the 17 metrics below, Cytosorbents Corporation leads on 10 and CVRx, Inc. on 7.

Valuation

Metric CTSO CVRX Medical Devices median
P/E n/m n/m 22.36
P/S 0.44 0.24 2.40
P/B n/m 1.05 2.34
Price to free cash flow n/m n/m 26.16
EV/EBITDA n/m n/m 10.97
EV/Sales 0.79 0.29 2.37
Earnings yield (110.27%) (379.25%) (11.89%)
Free cash flow yield (57.04%) (291.15%) (9.71%)

Profitability

Metric CTSO CVRX Medical Devices median
Gross margin 71.61% 86.90% 58.08%
Operating margin (34.74%) (81.90%) (17.17%)
Net margin (48.94%) (88.28%) (16.35%)
Free cash flow margin (25.32%) (69.69%) (6.21%)
Return on equity (336.17%) (172.17%) (21.47%)
Return on assets (42.38%) (53.55%) (17.83%)
Return on invested capital (66.90%) (224.98%) (8.54%)

Growth

Metric CTSO CVRX Medical Devices median
Revenue growth (TTM) 3.07% 7.79% 10.47%
EPS growth (last fiscal year) 65.79% 23.02% 28.60%
Revenue growth, 5-year CAGR (2.00%) 56.40% 15.88%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTSO CVRX Medical Devices median
Debt to equity (22.96) 4.24 0.05
Current ratio 0.66 6.80 2.81
Net debt to EBITDA (0.85) 0.52 0.53

Dividend

Metric CTSO CVRX Medical Devices median
Dividend yield — — 1.04%
Payout ratio — — 0.37

Size

Metric CTSO CVRX Medical Devices median
Market cap 17.54m 17.20m 200.67m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack